We next treated ESCC cells with C646, a histone acetyltransferase (HAT) inhibitor, and found that LAMC2 expression was significantly decreased in response (Supplementary Figure 3B). This evidence concerns the gene LAMC2 and esophageal squamous cell carcinoma.